A Study Of Diflucan In Children With Ringworm Of The Scalp
Public ClinicalTrials.gov record NCT00645242. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label, Multicenter Trial Of Diflucan (Fluconazole) For 6 Weeks Given Once Daily To Pediatric Patients With Tinea Capitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of fluconazole for the treatment of tinea capitis in pediatric patients aged 3 to 12 years.
Study identification
- NCT ID
- NCT00645242
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 185 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 3 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2002
- Primary completion
- Not listed
- Completion
- Feb 28, 2003
- Last update posted
- Jul 15, 2021
2002 – 2003
United States locations
- U.S. sites
- 28
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Montgomery | Alabama | 36116 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72205 | — |
| Pfizer Investigational Site | San Diego | California | 92123 | — |
| Pfizer Investigational Site | Miami | Florida | 33156-7712 | — |
| Pfizer Investigational Site | Miami | Florida | 33156 | — |
| Pfizer Investigational Site | Martinez | Georgia | 30907 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60630 | — |
| Pfizer Investigational Site | Evanston | Illinois | 60202 | — |
| Pfizer Investigational Site | Gretna | Louisiana | 70056 | — |
| Pfizer Investigational Site | New Orleans | Louisiana | 70119 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71105 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48201 | — |
| Pfizer Investigational Site | Fridley | Minnesota | 55432 | — |
| Pfizer Investigational Site | Bridgeton | Missouri | 63044 | — |
| Pfizer Investigational Site | Brooklyn | New York | 11203-2098 | — |
| Pfizer Investigational Site | Garner | North Carolina | 27529 | — |
| Pfizer Investigational Site | Raleigh | North Carolina | 27609 | — |
| Pfizer Investigational Site | Cleveland | Ohio | 44106 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43205 | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | 29464 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37927 | — |
| Pfizer Investigational Site | Murfreesboro | Tennessee | 37130 | — |
| Pfizer Investigational Site | Nashville | Tennessee | 37215 | — |
| Pfizer Investigational Site | Houston | Texas | 77056 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78205 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78224 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00645242, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2021 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00645242 live on ClinicalTrials.gov.